Fresenius Corporate Profile

Fresenius Corporate Profile

Financials

2020 Annual Revenue
€17.86 Billion

2020 Gross Profit
€5.44 Billion

2020 Annual Net Income
€1.12 Billion

2020 Fiscal Year Revenue Growth 
2.19%

2020 Number of Employees
125,364

Credit Rating

S&P Rated: Investment-Grade BBB (Long-Term)
*Fresenius Medical Care Holdings Inc.’s senior unsecured notes are rated “BBB” by S&P.

Fresenius Corporate Profile

Fresenius Corporate Profile

Fresenius Medical Care (NYSE: FMS) provides dialysis and related products, inpatient/outpatient care products, and services such as engineering to hospitals and related facilities. Fresenius operates more than 2,400 dialysis centers in North America and has over 125,000 employees. These facilities routinely provide medically necessary renal care to hundreds of thousands of patients with chronic kidney failure, a condition that affects more than 2.1 million individuals globally.

ExchangeRight

1055 E. Colorado Blvd, Suite 310
Pasadena, CA 91106

Phone: (855) 317-4448
Fax: (877) 711-4047
Email: info@exchangeright.com

Subscribe

Receive our investment announcements and equity updates.